Endometriosis: pain, fertility and intimate life

One woman in ten. Periods that pin you to the bed, pain during sex, sometimes infertility, and years of wandering before the diagnosis. What is known about the disease, how it is recognised and treated today, and how the couple lives with it.

Get our daily news watch

What it is

Endometriosis is the presence, outside the uterus, of tissue similar to the one that lines it — on the ovaries, the ligaments of the pelvis, the wall of the rectum or the bladder, more rarely elsewhere. This tissue reacts to the hormones of the cycle like the uterine lining: it bleeds, it becomes inflamed, it creates adhesions that stick organs together. The disease affects about one woman in ten of reproductive age, close to two hundred million people worldwide, and it often begins in adolescence. Its exact cause is unknown; what is known is that it is chronic, that it cannot be cured in the strict sense, that it can be treated well in most cases, and that it generally dies down at menopause. It is not a cancer and does not become one.

Accounts to follow

Submit your account

On social media

Posts spotted on 02 November 2026 about this topic, from official sources, media or recognised figures. They reflect their authors' views.

Video · X

Endometriosis: women describe ineffective pills, pain and fear of a diagnosis

— Women's accounts describe hormonal contraception that did not help, persistent bleeding and pain, and the fear of an endometriosis diagnosis.

X · @nexemesis

The signs that should bring it to mind

Young woman curled up on her bed with a hot-water bottle against her belly, in a softly lit bedroom
Period pain is common; being confined to bed by it is not.

None of these signs is specific, and the intensity of the pain says nothing about the extent of the lesions: small lesions can hurt a lot, large ones can go unnoticed. That is one of the reasons for the diagnostic delay — four to twelve years on average between the first symptoms and a name being put on them, depending on the estimate. The other reason is cultural: generations of women were told that period pain was normal.

How it is diagnosed today

A young woman lies on the table of an MRI scanner while a technologist in blue settles her before the examination
Transvaginal ultrasound and pelvic MRI: the diagnosis is now made without surgery.

Diagnosis has changed. It rests on the history — the precise calendar of the pain, its link with periods, sex, bowel movements —, the gynaecological examination, and imaging: a transvaginal ultrasound done by a practitioner trained to look for it, and a pelvic MRI for the deep forms. Laparoscopy, long the obligatory step, no longer is: international guidelines allow the diagnosis to be made and treatment started without operating, surgery being reserved for cases where it is therapeutic. There are three forms, which combine: superficial on the peritoneum, ovarian cysts — endometriomas —, and deep, which infiltrates neighbouring organs. A sister disease, adenomyosis, where the same tissue grows within the muscle of the uterus, gives heavy and painful periods and often accompanies endometriosis.

In France, a saliva test, Endotest, has been usable since February 2025 under special arrangements: covered for three years for up to 25,000 patients, prescribed by a gynaecologist and carried out in hospital, it is reserved for women aged 18 to 43 whose imaging is normal or inconclusive despite highly suggestive symptoms. The French health authority considers its first results encouraging but still insufficient to conclude that it benefits patients: the study that accompanies this coverage, by measuring whether the test changes doctors’ decisions, must supply the missing data before any lasting decision.

The treatments

A young woman takes a tablet from its blister above the sink, a glass of water in her hand
Hormonal treatments stop periods to put the lesions at rest; they relieve without removing the disease.

Care, reimbursement, the existence of specialist centres and recognition of the disease as a long-term condition vary a great deal from one country to another; that is a point to check with the patient associations of your country, which are often the best informed.

A new family of tablets has been added: oral GnRH antagonists, combined with a small dose of hormones to limit hot flushes and bone loss. Relugolix (in 2023), then linzagolix (in 2024), are authorised in the European Union for women whose endometriosis has already been treated with medication or surgery. For relugolix, an extension study without a comparison group showed an effect on pain maintained over two years, with an average fall in bone density of less than 1% that then stabilised; about a third of participants, however, stopped along the way. They are available on prescription only, and availability and reimbursement depend on the country.

Sex, and the couple

In a hospital waiting area, a man holds his partner's hand and looks at her attentively
Going to appointments together: a chronic illness is easier to carry as a pair.

Pain during sex is the symptom least talked about and the one that weighs most on the couple: it installs avoidance, avoidance installs distance, and the partner ends up feeling guilty about a body she did not choose. A few markers. Deep pain often depends on position and depth: those where the woman controls the movement, or shallower positions, change a lot. It depends on the time of the cycle: the days before the period are the worst, and knowing this allows choosing. It does not require penetration: sex without penetration during painful periods is not a renunciation, it is an adaptation, and many couples discover on this occasion what the page on desire and pleasure describes. And it can be treated: a hormonal treatment that calms the lesions also calms sex; a pelvic-floor physiotherapist relaxes muscles which, from anticipating pain, tighten before any contact. What not to do: grit your teeth. Pain endured in silence maintains the contraction reflex and teaches the body to dread sex.

For the partner, the role is simple to state and hard to hold: believe the pain — it is neither exaggerated nor “in the head” —, do not take it as a rejection of oneself, and come along to appointments, because a chronic illness is better carried by two.

When to seek help

A young woman consults a midwife in a health centre, a closed notebook in front of her
GP or midwife first, then a gynaecologist used to endometriosis: ultrasound only sees it if one looks for it.

As soon as periods prevent a normal life, as soon as sex hurts deep inside, as soon as a pregnancy is slow in coming beyond a year — six months after thirty-five — with painful periods. The family doctor or midwife first, the gynaecologist next, and preferably a practitioner or a centre used to endometriosis, because the ultrasound only sees it if one looks for it. The page who to see, and when details the referral.

Recognition and care by country

Chronic-disease status, national plans, specialist centres, menstrual leave: what each country provides is summarised in the country table on the menstrual cycle page, with a full page for the countries where there is enough to say.

State of research

Research reviewed in October 2026. The main challenge remains diagnosis without surgery. No blood marker is validated today to replace examination: as early as 2016, a Cochrane review of 141 studies concluded that none could be used outside research. Combinations of blood proteins give promising results, for example in an Australian study of 805 participants, but still need to be confirmed in other populations, and that study was run by the company that patented the test; the saliva test described above is also being evaluated.

Researchers also want to understand why some lesions are very painful and others not at all. A study published in 2026 compared lesions from women with and without pain: nearly 900 genes are expressed differently, including genes involved in inflammation, and one molecule, IL16, is linked to the intensity of pain. This is basic research on 19 patients: a lead for future treatments, not a test or a medicine available today.

Among hormone-free leads, a derivative of an old antiparasitic drug, delivered by nanoparticles, gave encouraging results in mice; it has not yet been tested in women. Closer to patients, a five-year trial led by the University of Aberdeen, in preparation since 2026 in the United Kingdom, will assess whether a personalised twelve-week programme (medication, physiotherapy, psychological support…) improves quality of life for women whose pain remains poorly relieved; recruitment has not yet started.

Frequently asked questions

Does pregnancy cure endometriosis?

No. Pregnancy suspends periods and therefore, often, the symptoms, which return afterwards. “Have a baby, it will pass” is advice still heard and without foundation.

Does the pill hide the disease?

It calms it, and that is precisely why it is prescribed. Many women discover endometriosis on stopping a contraceptive taken since adolescence, when the pain returns: the pill did not create the disease, it was holding it back.

Is it hereditary?

The risk is several times higher when the mother or a sister is affected, which justifies not letting very painful periods drag on in a teenager whose family knows the disease. But there is no endometriosis gene, and most affected women have no known family history.

Do diet, exercise or osteopathy help?

Regular physical activity reduces chronic pain in general, and some women notice an improvement when changing their diet; none of these approaches has proved any effect on the lesions themselves. They can complement a treatment, not replace it.

Who to see for this problem?

The page Who to see, and when gives, symptom by symptom, the right professional — family doctor, urologist, gynaecologist, sex therapist, psychologist — and the emergencies that cannot wait.

Research

Ovarian or deep endometriosis: IVF yields more live births than surgery in an Italian study

— In a study published in the American Journal of Obstetrics & Gynecology, women with ovarian or deep endometriosis had about twice the rate of live birth within 12 months of IVF as after surgery (relative risk 2.20, randomised arm). It is a partially randomised patient-preference trial; the authors warn against reading the results as a blanket case for IVF.

Endometriosis: different beliefs about the body's signals, linked to pain

— A European Journal of Pain study compares 247 people with endometriosis with 98 people without it. Those with the condition notice internal signals more, trust them less and worry more about them; the more pain, the more attention they pay to them.

Endometriosis: discovery of a non-hormonal metabolic target (pyruvate carboxylase) and long-term mental health impact

— Three autumn 2026 studies shed new light on endometriosis: research in Reproductive BioMedicine Online identifies the enzyme pyruvate carboxylase as a metabolic driver of lesion invasion (opening a non-hormonal pathway), a cohort study in Human Reproduction tracks the persistent rise in antidepressant and anxiolytic prescriptions, and JOGC evaluates patient-specific 3D-printed surgical models.

UK: a trial on managing endometriosis pain

— The University of Aberdeen is preparing a five-year, £2.3 million trial of a personalised twelve-week programme (medication, physiotherapy, psychological support) for women whose pain remains poorly relieved. Recruitment has not started and no results are known yet.

Endometriosis: a lead on why some lesions hurt

— Yale researchers compared lesions from 19 women with or without pain: nearly 900 genes are expressed differently, and an inflammatory molecule, IL16, is linked to the intensity of pain. This is basic research on a small group: no test or treatment results from it yet.

Sources

  1. Instruction n° DGOS/R4/2022/183 du 12 juillet 2022 relative à l'organisation, sur les territoires, de filières dédiées à la prise en charge de l'endométriose — sante.gouv.fr, 12 j (Français)
  2. Épidémiologie de l'endométriose prise en charge à l'hôpital en France : étude nationale de 2011 à 2017 à partir des données du SNDS — Santé publique France, French national public health agency, 9 ma (Français)
  3. Étude de faisabilité de la surveillance épidémiologique de l'endométriose en France et premières estimations d'incidence (ré-hospitalisations et formes profondes) — Santé publique France, French national public health agency, 14 j (Français)
  4. Améliorer la qualité du système de santé et maîtriser les dépenses : Propositions de l'Assurance Maladie pour 2025 (Focus Endométriose et prise en charge en ALD 31) — assurance-maladie.ameli.fr, Juil (Français)
  5. Prise en charge de l'endométriose — Recommandations de bonne pratique conjointes HAS / CNGOF (Démarche diagnostique, traitements médicaux et chirurgicaux) — has-sante.fr, 17 j (Français)
  6. Actualisation de la place des différents examens d'imagerie pour le diagnostic d'endométriose — Recommandation de bonne pratique labellisée HAS / SIFEM / SFR / CNGOF — has-sante.fr, 15 m (Français)
  7. Évaluation du test salivaire Endotest® dans les situations complexes de diagnostic d'endométriose — Rapport d'évaluation technologique et Avis n° 2023.0048/AC/SEAP — has-sante.fr, 8 ja (Français)
  8. Arrêté du 6 février 2025 (JORF du 11 février 2025) relatif à la prise en charge du dispositif médical in vitro ENDOTEST au titre de l'article L. 165-1-1 du Code de la sécurité sociale — ziwig.com, 6 fé (Français)
  9. Saliva microRNA signature to diagnose endometriosis: A cost-effectiveness evaluation of the Endotest® in the French healthcare setting — doi.org, 19 d (Anglais)
  10. ESHRE Guideline: Management of women with endometriosis (Diagnostic, prise en charge de la douleur, dyspareunie et fertilité) — doi.org, 2022 (Anglais)
  11. Deep Dyspareunia in Endometriosis: Role of the Bladder and Pelvic Floor (Mécanismes myofasciaux et sensibilisation centrale) — doi.org, Août (Anglais)
  12. Endometriosis-Related Chronic Pelvic Pain: Peripheral, Central, and Cross-Sensitization Mechanisms — doi.org, 23 o (Anglais)
  13. Dyspareunia in Women: Differential Diagnosis (Superficial vs Deep Dyspareunia, Vulvodynia, Vaginismus, and Endometriosis) and Clinical Management — pubmed.ncbi.nlm.nih.gov, 15 m (Anglais)
  14. Female Sexual Dysfunctions and Urogynecological Complaints: Interplay Between Deep Endometriosis, High-Tone Pelvic Floor Dysfunction, and Secondary Vaginismus — doi.org, 23 j (Anglais)
  15. Vaginismus treatment: a systematic review and meta-analysis of contemporary therapeutic approaches (18 studies, 863 patients) — consensus.app, 2025 (Anglais)
  16. The Effectiveness of Therapeutic Interventions on Sexual Function in Women with Vaginismus: A Systematic Review and Meta-Analysis of 15 Randomized Controlled Trials (n = 950) — consensus.app, 2026 (Anglais)
  17. Effectiveness of physical therapy interventions in women with dyspareunia and endometriosis: Systematic reviews and meta-analyses (Fernández-Pérez 2023 & Mena-González 2026) — consensus.app, 2023 (Anglais)
  18. Surgical versus low-dose progestin treatment for endometriosis-associated severe deep dyspareunia: effect on sexual functioning, psychological status and quality of life — consensus.app, 2013 (Anglais)
  19. Endometriosis and Reproductive Sparing Surgery: Evaluation of International Guidelines (ESHRE 2022, NICE 2024, S2k 2025) and Role of Vaginal Dilator Therapy (Little 2023) — doi.org, 4 ja (Anglais)
  20. Endométriose : symptômes, diagnostic, évolution et traitements — Dossier patient de référence de l'Assurance Maladie et du Service Public d'Information en Santé — ameli.fr, 19 j (Français)

Official or institutional documents this page relies on, consulted on 28 octobre 2026. Links open in a new tab.

Further reading

Verified links to official or reference sources. They open in a new tab.

Content updated in . The data cited can change.

Text written with the help of AI, under the editorial responsibility of CAPIT; human reviews are occasional (method and sources: About). This content does not replace medical or legal advice. Spotted an error? Write to us.

Locate this page in the site map